$SPRY 4 SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Casale Donn, Director Granted 1,036,923 Stock Option (right to buy)
02 Sep 2026	Form 4: Smith Margaret Ekins, Chief Commercial Officer Granted 1,001,738 Stock Option (right to buy)
02 Jul 2026	Form 4: Casale Donn, President Granted 898,456 Stock Option (right to buy)
26 Jun 2026	Form 4: Ra Capital MANAGEMENT, L.p., Director and 4 others Granted 30,000 Stock Option (Right to Buy)
26 Jun 2026	Form 4: Dadoo Rajeev, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Shah Pratik, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Kelly Michael, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Islam Saqib, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Thompson Peter A., Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Saunders Brent L, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Schneider Phillip M, Director Granted 30,000 Stock Option (right to buy)
26 Jun 2026	Form 4: Shawver Laura, Director Granted 30,000 Stock Option (right to buy)
12 Jun 2026	Form 4: Karas Eric, Chief Commercial Officer Received 25,000 shares by exercise or conversion ($37.5K) · Sold 25,000 shares ($250K)
12 Jun 2026	Form 4: Fitzpatrick Alexander A, Chief Legal Officer Sold 3,355 shares ($33.6K)
05 Jan 2026	Form 4: Karas Eric, Chief Commercial Officer Granted 240,000 Stock option (right to buy)
05 Jan 2026	Form 4: Scott Kathleen D., Chief Financial Officer Granted 240,000 Stock option (right to buy)
05 Jan 2026	Form 4: Fitzpatrick Alexander A, Chief Legal Officer Granted 240,000 Stock option (right to buy)
05 Jan 2026	Form 4: Dorsey Brian, Chief Operating Officer Granted 240,000 Stock option (right to buy)
05 Jan 2026	Form 4: Chakma Justin, Chief Business Officer Granted 240,000 Stock option (right to buy)
05 Jan 2026	Form 4: Tanimoto Sarina, CHIEF MEDICAL OFFICER Granted 240,000 Stock option (right to buy) · Granted 875,000 Stock Option (right to buy)

Comments